Annual CFI
$0.00
+$5700.00+100.00%
30 September 2023
Summary:
Edesa Biotech annual cash flow from investing activities is currently $0.00, with the most recent change of +$5700.00 (+100.00%) on 30 September 2023. During the last 3 years, it has risen by +$6100.00 (+100.00%). EDSA annual CFI is now -100.00% below its all-time high of $6.42 million, reached on 30 September 2019.EDSA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
N/A
30 June 2024
Summary:
Edesa Biotech quarterly cash flow from investing activities is not available.EDSA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
N/A
30 June 2024
Summary:
Edesa Biotech TTM cash flow from investing activities is not available.EDSA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EDSA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +100.0% | - | - |
| 5 y5 years | -100.0% | - | - |
EDSA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | +100.0% | |||||
| 5 y | 5 years | -100.0% | +100.0% | ||||
| alltime | all time | -100.0% | +100.0% |
Edesa Biotech Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2022 | - | $0.00(0.0%) | -$2600.00(-54.4%) |
| Sept 2022 | -$5700.00(-6.6%) | $0.00(-100.0%) | -$5700.00(+35.7%) |
| June 2022 | - | -$1400.00(+16.7%) | -$4200.00(-33.3%) |
| Mar 2022 | - | -$1200.00(-61.3%) | -$6300.00(-22.2%) |
| Dec 2021 | - | -$3100.00(-306.7%) | -$8100.00(+32.8%) |
| Sept 2021 | -$6100.00(-131.9%) | $1500.00(-142.9%) | -$6100.00(+48.8%) |
| June 2021 | - | -$3500.00(+16.7%) | -$4100.00(-85.0%) |
| Mar 2021 | - | -$3000.00(+172.7%) | -$27.40 K(-105.5%) |
| Dec 2020 | - | -$1100.00(-131.4%) | $495.30 K(+2493.2%) |
| Sept 2020 | $19.10 K(-99.7%) | $3500.00(-113.1%) | $19.10 K(+22.4%) |
| June 2020 | - | -$26.80 K(-105.2%) | $15.60 K(-63.2%) |
| Mar 2020 | - | $519.70 K(-208.9%) | $42.40 K(-96.0%) |
| Dec 2019 | - | -$477.30 K(-131.0%) | $1.06 M(+313.5%) |
| Sept 2019 | $6.42 M(-243.7%) | - | - |
| Mar 2019 | - | $1.54 M(-65.6%) | $256.70 K(-126.9%) |
| Dec 2018 | - | $4.47 M(-803.5%) | -$954.20 K(-78.6%) |
| Sept 2018 | -$4.47 M(-364.0%) | -$635.90 K(-87.6%) | -$4.47 M(+131.5%) |
| June 2018 | - | -$5.12 M(-1661.7%) | -$1.93 M(-162.0%) |
| Mar 2018 | - | $327.80 K(-65.9%) | $3.11 M(+13.5%) |
| Dec 2017 | - | $961.10 K(-49.4%) | $2.74 M(+62.1%) |
| Sept 2017 | $1.69 M(+203.5%) | $1.90 M(-2575.1%) | $1.69 M(-173.4%) |
| June 2017 | - | -$76.80 K(+77.8%) | -$2.31 M(-0.9%) |
| Mar 2017 | - | -$43.20 K(-51.6%) | -$2.33 M(-460.9%) |
| Dec 2016 | - | -$89.20 K(-95.7%) | $644.90 K(+15.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | $557.40 K(+355.0%) | -$2.10 M(+2035.5%) | $557.50 K(-78.3%) |
| June 2016 | - | -$98.20 K(-103.4%) | $2.57 M(+2.3%) |
| Mar 2016 | - | $2.93 M(-1758.8%) | $2.52 M(-650.4%) |
| Dec 2015 | - | -$176.60 K(+117.8%) | -$457.00 K(-473.4%) |
| Sept 2015 | $122.50 K(-1035.1%) | -$81.10 K(-48.2%) | $122.40 K(-102.3%) |
| June 2015 | - | -$156.50 K(+265.7%) | -$5.26 M(+2.4%) |
| Mar 2015 | - | -$42.80 K(-110.6%) | -$5.14 M(-3.5%) |
| Dec 2014 | - | $402.80 K(-107.4%) | -$5.33 M(-7.2%) |
| Sept 2014 | -$13.10 K(-99.8%) | - | - |
| Aug 2014 | -$5.75 M(>+9900.0%) | -$5.47 M(>+9900.0%) | -$5.75 M(+1907.6%) |
| May 2014 | - | -$34.40 K(-85.1%) | -$286.20 K(+13.7%) |
| Feb 2014 | - | -$231.40 K(+1639.8%) | -$251.80 K(+1134.3%) |
| Nov 2013 | - | -$13.30 K(+87.3%) | -$20.40 K(+114.7%) |
| Aug 2013 | -$9500.00(-87.9%) | -$7100.00(<-9900.0%) | -$9500.00(-82.6%) |
| May 2013 | - | $0.00(0.0%) | -$54.60 K(-21.1%) |
| Feb 2013 | - | $0.00(-100.0%) | -$69.20 K(-4.3%) |
| Nov 2012 | - | -$2400.00(-95.4%) | -$72.30 K(-7.8%) |
| Aug 2012 | -$78.30 K(-74.7%) | -$52.20 K(+257.5%) | -$78.40 K(-1.4%) |
| May 2012 | - | -$14.60 K(+371.0%) | -$79.50 K(+5.2%) |
| Feb 2012 | - | -$3100.00(-63.5%) | -$75.60 K(-37.3%) |
| Nov 2011 | - | -$8500.00(-84.1%) | -$120.60 K(-61.1%) |
| Aug 2011 | -$309.80 K(+248.5%) | -$53.30 K(+398.1%) | -$309.80 K(+20.8%) |
| May 2011 | - | -$10.70 K(-77.8%) | -$256.50 K(+4.4%) |
| Feb 2011 | - | -$48.10 K(-75.7%) | -$245.80 K(+24.3%) |
| Nov 2010 | - | -$197.70 K | -$197.70 K |
| Aug 2010 | -$88.90 K | - | - |
FAQ
- What is Edesa Biotech annual cash flow from investing activities?
- What is the all time high annual CFI for Edesa Biotech?
- What is the all time high quarterly CFI for Edesa Biotech?
- What is the all time high TTM CFI for Edesa Biotech?
What is Edesa Biotech annual cash flow from investing activities?
The current annual CFI of EDSA is $0.00
What is the all time high annual CFI for Edesa Biotech?
Edesa Biotech all-time high annual cash flow from investing activities is $6.42 M
What is the all time high quarterly CFI for Edesa Biotech?
Edesa Biotech all-time high quarterly cash flow from investing activities is $4.47 M
What is the all time high TTM CFI for Edesa Biotech?
Edesa Biotech all-time high TTM cash flow from investing activities is $3.11 M